Compared to agonists, researchers have identified only a few natural compounds that inhibit PPARγ, all of which have a moderate binding affinity for PPARγ receptor and can inhibit adipogenesis, obesity, and/or hepatic steatosis. This evidence concerns the gene PPARG and Obesity.